Master of Science in Cell and Gene Therapies
Join the forefront of discovery and accelerate your career with a Master of Science in Cell and Gene Therapies.
The College of Science prepares graduates for the future of work. 95% of our graduates secure employment opportunities soon after completing their degree. (2021 graduate survey data)
A master’s degree holder can expect to earn an average of 20 percent more than someone who has only earned their bachelor’s degree. (U.S. Bureau of Labor Statistics, 2021).
In New England, jobs related to regenerative medicine are expected to grow by 10.8 percent over the next decade—with salaries for professional workers in related occupations above the national average.
Northeastern University’s Master of Science in Cell and Gene Therapies is an innovative nonthesis degree program that prepares students for the evolving field of cell and gene therapy medicines. The industry-aligned curriculum provides the knowledge and experience to advance your biotechnology career.
- 2-2.5 years
- Full-time & part-time offerings
- On-campus in Boston, MA
Program does meet F1 Visa Requirements
- Fall Domestic: August 15
- Spring Domestic: December 1
- Fall International: July 1
- Spring International: November 1
- International currently on a F1 visa in the US
- Spring: November 15
2 letters of recommendation
Minimum GPA of 3.0
English language proficiency:
- Degree earned or in progress at a US/Canadian institution
- Degree earned or in progress at an institution where English is the only medium of instruction
- Official exam scores from either the TOEFL iBT (institution code is 3682), IELTS, PTE exam, or Duolingo English Test. Scores are valid for 2 years from the test date.
Get involved in our research
Our faculty are involved in seven research centers, labs, and institutes focused on biotechnology including Antimicrobial Discovery Center, Barnett Institute of Chemical and Biological Analysis, Center for Pharmaceutical Biotechnology and Nanomedicine. Learn more here.
Delve into your future career path on co-op
Students in the MS in Cell and Gene Therapies program gain real-world knowledge, awareness, perspective, and confidence during a three- to six-month graduate co-op in industry, academia, or government. As the recognized leader in experiential learning and a trusted source of high-caliber students, Northeastern boasts a network of more than 3,000 public and private sector co-op locations on seven continents. Recent biotechnology co-op placements have included Biogen Idec, EMD Serono/Millipore, Harvard Medical School, Medimmune, Momenta Pharmaceuticals, New England Biolabs, Regeneron, Novartis, and Genzyme, among others. Learn more here.
Earning a degree at Northeastern opens the door to a network of more than 275,000 alumni and 3,350+ employer partners, including government agencies, Fortune 500 companies, and global nongovernmental organizations. As a result, our community expands continents, furthering our commitment to global, lifelong connections. Learn more here.
Want to learn more? Submit your information and we’ll reach out.